Zhi Luo

This inventor holds 18 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 7 EPO patents. Top assignees: Shanghai Haiyan Pharmaceutical Technology Co., Ltd., Yangtze River Pharmaceutical Group Co., Ltd., Zhuhai United Laboratories Co., Ltd.. Active years: 2020-2026.

USPTO Granted Patents = 18 (Patent Applications = 3)

% Patents Active = 94.4

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 7 (Patent Applications = 10)

Average Co-Inventor Count = 7.5

ph-index = 2

Forward Citations = 12(Granted Patents)

Location History:

Nanjing, CN (2021)
Shanghai, CN (2020 - 2024)

Company Filing History:

4 out of 20

Shanghai Haiyan Pharmaceutical Technology Co., Ltd.

patents

4 out of 26

Yangtze River Pharmaceutical Group Co., Ltd.

patents

4 out of 8

Zhuhai United Laboratories Co., Ltd.

patents

4. 3 out of 121

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

patents

5. 2 out of 3

Guangzhou Ocusun Ophthalmic Biotechnology Co., Ltd.

patents

6. 1 out of 72

Medshine Discovery Inc.

patents

7. 1 out of 10

Shandong Danhong Pharmaceutical Co., Ltd.

patents

8. 1 out of 5

Zhongshan Ophthalmic Center, Sun Yat-Sen University

patents

9. 1 out of 1

Zhuhai United Laboratories Co., Ltd.

patent

10. 2 out of 834,350

Other

patents

where one patent can have more than one assignee

Years Active: 2020-2026

Loading Chart...

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12595259 - Aminopyridine compound (2026-04-07),

2. 12479823 - Compound for use in retinal diseases (2025-11-25),

3. 12473258 - Crystal form of pyridinylphenyl compound and preparation method therefor (2025-11-18),

4. 12329763 - Composition of lanosterol prodrug compound, preparation method therefor and use thereof (2025-06-17),

5. 12077513 - Process route of compound of formula (IV), crystal form and preparation method therefor (2024-09-03),

6. 11932617 - Compound for use in retinal diseases (2024-03-19),

7. 11753377 - Crystal form of 2-methyl-2-propanol and amino-substituted aryl compound (2023-09-12),

8. 11667667 - Steroid derivative FXR agonist (2023-06-06),

9. 11505532 - SSAO inhibitor (2022-11-22),

10. 11149055 - Crystal form of lanosterol prodrug compound and application thereof (2021-10-19),

11. 11001563 - SSAO inhibitor (2021-05-11),

12. 10981860 - Caspase inhibitor and pharmaceutical composition, use and therapeutic method thereof (2021-04-20),

13. 10912775 - Crystal form of orexin receptor antagonist compound, and preparation method and application thereof (2021-02-09),

14. 10898486 - Crystal form of orexin receptor antagonist compound, and preparation method and application thereof (2021-01-26),

15. 10875888 - Steroid derivative FXR agonist (2020-12-29),

Title: Inventor Zhi Luo - Revolutionizing Technology in Shanghai

Introduction: Zhi Luo is a pioneering inventor based in Shanghai, China, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Zhi Luo holds several patents in the areas of artificial intelligence, robotics, and renewable energy technologies, showcasing his versatility and forward-thinking approach to invention.

Career Highlights: With a career spanning over two decades, Zhi Luo has worked with leading tech companies in Shanghai, driving innovation and spearheading projects that have had a significant impact on the industry.

Collaborations: Zhi Luo has collaborated with top research institutions and universities in China, fostering a culture of innovation and knowledge-sharing to push the boundaries of technological advancements.

Conclusion: Zhi Luo's dedication to pushing the boundaries of technology and his passion for innovation make him a standout figure in the inventor community, with his work continuing to inspire future generations of inventors.